These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

505 related items for PubMed ID: 18679115

  • 1. Does granulocyte colony-stimulating factor ameliorate the proinflammatory response in human meningococcal septic shock?
    Rojahn A, Brusletto B, Øvstebø R, Haug KB, Kierulf P, Brandtzaeg P.
    Crit Care Med; 2008 Sep; 36(9):2583-9. PubMed ID: 18679115
    [Abstract] [Full Text] [Related]

  • 2. Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex.
    Bjerre A, Brusletto B, Øvstebø R, Joø GB, Kierulf P, Brandtzaeg P.
    J Endotoxin Res; 2003 Sep; 9(3):155-63. PubMed ID: 12831456
    [Abstract] [Full Text] [Related]

  • 3. Plasma interferon-gamma and interleukin-10 concentrations in systemic meningococcal disease compared with severe systemic Gram-positive septic shock.
    Bjerre A, Brusletto B, Høiby EA, Kierulf P, Brandtzaeg P.
    Crit Care Med; 2004 Feb; 32(2):433-8. PubMed ID: 14758160
    [Abstract] [Full Text] [Related]

  • 4. Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes.
    Brandtzaeg P, Osnes L, Ovstebø R, Joø GB, Westvik AB, Kierulf P.
    J Exp Med; 1996 Jul 01; 184(1):51-60. PubMed ID: 8691149
    [Abstract] [Full Text] [Related]

  • 5. Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.
    Sprong T, Pickkers P, Geurts-Moespot A, van der Ven-Jongekrijg J, Neeleman C, Knaup M, Leroy D, Calandra T, van der Meer JW, Sweep F, van Deuren M.
    Shock; 2007 May 01; 27(5):482-7. PubMed ID: 17438452
    [Abstract] [Full Text] [Related]

  • 6. Influence of innate cytokine production capacity on clinical manifestation and severity of pediatric meningococcal disease.
    Sprong T, van der Ven-Jongekrijg J, Neeleman C, van der Meer JW, van Deuren M.
    Crit Care Med; 2009 Oct 01; 37(10):2812-8. PubMed ID: 19707127
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-4 inhibits granulocyte-macrophage colony-stimulating factor, interleukin-6, and tumor necrosis factor-alpha expression by human monocytes in response to polymethylmethacrylate particle challenge in vitro.
    Trindade MC, Nakashima Y, Lind M, Sun DH, Goodman SB, Maloney WJ, Schurman DJ, Smith RL.
    J Orthop Res; 1999 Nov 01; 17(6):797-802. PubMed ID: 10632444
    [Abstract] [Full Text] [Related]

  • 8. Down-modulation of granulocyte macrophage-colony stimulating factor receptor on monocytes during human septic shock.
    Pangault C, Le Tulzo Y, Tattevin P, Guilloux V, Bescher N, Drénou B.
    Crit Care Med; 2006 Apr 01; 34(4):1193-201. PubMed ID: 16484916
    [Abstract] [Full Text] [Related]

  • 9. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S, Kreuzfelder E, Waydhas C, Schade FU, Flohé S.
    Inflamm Res; 2007 Jan 01; 56(1):38-44. PubMed ID: 17334669
    [Abstract] [Full Text] [Related]

  • 10. Dissociation of LPS-induced monocytic ex vivo production of granulocyte colony-stimulating factor (G-CSF) and TNF-alpha in patients with septic shock.
    Weiss M, Fischer G, Barth E, Boneberg E, Schneider EM, Georgieff M, Hartung T.
    Cytokine; 2001 Jan 07; 13(1):51-54. PubMed ID: 11145842
    [Abstract] [Full Text] [Related]

  • 11. Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration.
    Kleinerman ES, Knowles RD, Lachman LB, Gutterman JU.
    Cancer Res; 1988 May 01; 48(9):2604-9. PubMed ID: 3128401
    [Abstract] [Full Text] [Related]

  • 12. Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma.
    Flohé S, Lendemans S, Selbach C, Waydhas C, Ackermann M, Schade FU, Kreuzfelder E.
    Crit Care Med; 2003 Oct 01; 31(10):2462-9. PubMed ID: 14530752
    [Abstract] [Full Text] [Related]

  • 13. A new dynamic porcine model of meningococcal shock.
    Nielsen EW, Hellerud BC, Thorgersen EB, Castellheim A, Pharo A, Lindstad J, Tønnessen TI, Brandtzaeg P, Mollnes TE.
    Shock; 2009 Sep 01; 32(3):302-9. PubMed ID: 19174740
    [Abstract] [Full Text] [Related]

  • 14. Response of tumour necrosis factor-alpha to delayed in vitro monocyte stimulation in patients with septic shock is related to outcome.
    Appoloni O, Vincent JL, Duchateau J.
    Clin Sci (Lond); 2002 Mar 01; 102(3):315-20. PubMed ID: 11869172
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock.
    Venet F, Tissot S, Debard AL, Faudot C, Crampé C, Pachot A, Ayala A, Monneret G.
    Crit Care Med; 2007 Aug 01; 35(8):1910-7. PubMed ID: 17568330
    [Abstract] [Full Text] [Related]

  • 19. Gastric mucosal acidosis and cytokine release in patients with septic shock.
    Tamion F, Richard V, Sauger F, Menard JF, Girault C, Richard JC, Thuillez C, Leroy J, Bonmarchand G.
    Crit Care Med; 2003 Aug 01; 31(8):2137-43. PubMed ID: 12973171
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.